• Biomolecules & Therapeutics
• /
• 제16권3호
• /
• pp.179-183
• /
• 2008

In the present study, we examined the effects of several therapeutics of Alzheimer's disease, such as donepezil hydrochloride, tacrine and $\alpha$-phenyl-n-tert-butyl nitrone (PBN) on choline efflux from brain to circulating blood. The brain-to-blood efflux of [$^3H$]choline in rats was significantly inhibited by tacrine and PBN. Also the [$^3H$]choline efflux was reduced by tacrine and donepezil hydrochloride in the TR-BBB cells, in vitro the blood-brain barrier (BBB) model. These results suggest that these drugs may influence choline efflux transport from brain to blood and regulate the choline level in brain resulting in the increase of acetylcholine synthesis.

• Biomolecules & Therapeutics
• /
• 제28권6호
• /
• pp.503-511
• /
• 2020

Autophagy is a major catabolic process that maintains cell metabolism by degrading damaged organelles and other dysfunctional proteins via the lysosome. Abnormal regulation of this process has been known to be involved in the progression of pathophysiological diseases, such as cancer and neurodegenerative disorders. Although the mechanisms for the regulation of autophagic pathways are relatively well known, the precise regulation of this pathway in the treatment of cancer remains largely unknown. It is still complicated whether the regulation of autophagy is beneficial in improving cancer. Many studies have demonstrated that autophagy plays a dual role in cancer by suppressing the growth of tumors or the progression of cancer development, which seems to be dependent on unknown characteristics of various cancer types. This review summarizes the key targets involved in autophagy and malignant transformation. In addition, the opposing tumor-suppressive and oncogenic roles of autophagy in cancer, as well as potential clinical therapeutics utilizing either regulators of autophagy or combinatorial therapeutics with anti-cancer drugs have been discussed.

• Bulletin of the Korean Chemical Society
• /
• 제34권2호
• /
• pp.673-676
• /
• 2013

• Journal of Microbiology and Biotechnology
• /
• 제29권6호
• /
• pp.845-855
• /
• 2019

Synthetic biology builds programmed biological systems for a wide range of purposes such as improving human health, remedying the environment, and boosting the production of valuable chemical substances. In recent years, the rapid development of synthetic biology has enabled synthetic bacterium-based diagnoses and therapeutics superior to traditional methodologies by engaging bacterial sensing of and response to environmental signals inherent in these complex biological systems. Biosynthetic systems have opened a new avenue of disease diagnosis and treatment. In this review, we introduce designed synthetic bacterial systems acting as living therapeutics in the diagnosis and treatment of several diseases. We also discuss the safety and robustness of genetically modified synthetic bacteria inside the human body.

• Translational and Clinical Pharmacology
• /
• 제26권4호
• /
• pp.172-176
• /
• 2018

Mandatory registration of clinical trials in public registry can ensure the transparency of clinical trials. Public clinical trial registry of can provide current chronological and geographical distribution of clinical trial throughout the country. We used public clinical trial registry provided by Ministry of Food and Drug Safety to analyze current status of clinical trial from 2014 to 2016 in South Korea. The number of clinical trials in antineoplastic and immunomodulating agents area was the greatest, followed by cardiovascular system and antiinfectives for systemic use as a whole. From 2014 to 2016, overall number of clinical trials decreased while the number of phase I clinical trials increased. Seoul accounted for more than half number of clinical trials in Korea. Supports for clinical trials in non-metropolitan area needs to be considered.

• Biomolecules & Therapeutics
• /
• 제25권1호
• /
• pp.1-3
• /
• 2017

• Translational and Clinical Pharmacology
• /
• 제26권3호
• /
• pp.101-102
• /
• 2018

• Journal of Acupuncture Research
• /
• 제24권3호
• /
• pp.9-18
• /
• 2007

Objectives: Bloodletting therapeutics is one of the most popular oriental medical treatments in Korea. In this study, we operate the Interview Survey for grasping clinical actual state bloodletting therapeutics in Korea. Methods : Survey questions were developed based on consensus of acupuncture professors. The list of the Korean medical doctors with experiences more than 10 years is provided by the Association of the Korean Oriental Medicine. The interviews were conducted to 39 members of the Korean medical doctors who answered to used bloodletting therapeutics over 30 percentage a day at previous telephone survey. Interview survey with them were conducted by the well-trained interviewers of College of Korean Medicine student from 29th May 2006 to 3rd June 2006. Results : Korean medical doctors prefer to use the bloodletting cupping treatment(89.5%) on the bloodletting therapeutics. Musculo-skeletal disorder was as frequent as 89.5% of treatment disease. The most common treatment area was back(57.9%), extremity(l5.8%), pain area(l0.5%). The most common instrument for treating was disposable lancet(57.9%), three-edged needle(26.3%). Most Korean medical doctors(60.5%) took up the position that bring symptom relief following good treatment area. 'Recover quickly from illness'(50%) was one of bloodletting good points but 'Sever pain'(34.2%) was a weak points. Conclusion : This survey provides unique insight into the perception of the Korean medical doctors at bloodletting therapeutics. Most doctors experienced symptom relief, received positive benefits from the treatment. Future research needs to provide more in-depth insight into doctor views of the experience.

• Journal of Acupuncture Research
• /
• 제23권6호
• /
• pp.177-187
• /
• 2006

Objectives : Bloodletting therapeutics is one of the most popular oriental treatments in Korea. In this study, we operate the Telephone Survey for grasping clinical actual state bloodletting therapeutics in Korea. Methods : The list of the Korean medical doctors with experiences more than 10 years is provided by the Association of the Korean Oriental Medicine. A stratified random sample of Korean medical doctors is drawn for the telephone interviews. We choose a bound on the error of estimation equal to 3.2 percentage, and the sample size is 321 for the national sample. We develop a questionnaire for telephone interviews. We carefully design the questionnaire to minimize non-sampling errors by using the focus group activities and the pretest. We give the details of the results based on the sample design. Also, we present some socialdemograhpic characteristics for the samples. Telephone interviews with them were conducted by the well-trained interviewers of College of Korean Medicine student from 11th May 2006 to 17th May 2006. Results : 1. Two hundred eighty eight(89.4%) out of 322 Korean oriental medical doctors used bloodletting therapeutics. 2. The most common main bloodletting treatment is reported by patients was musculo-skeletal disorder(60.2%). 3. Two hundred ninety one(90.3%) out of 322 Korean oriental medical doctors opposed that commercial using bloodletting without medical diagnosis. Conclusion : Bloodletting therapeutics is one of the most popular oriental treatments in Korea. The majority(89.4%) of Korean medical doctors used bloodletting therapeutics in this survey.

• Biomolecules & Therapeutics
• /
• 제25권4호
• /
• pp.396-403
• /
• 2017

Under normal, non-stressed conditions, intracellular p53 is continually ubiquitinated by MDM2 and targeted for degradation. However, in response to severe genotoxic stress, p53 protein levels are markedly increased and apoptotic cell death is triggered. Inhibiting the ubiquitination of p53 under conditions where DNA damage has occurred is therefore crucial for preventing the development of cancer, because if cells with severely damaged genomes are not removed from the population, uncontrolled growth can result. However, questions remain about the cellular mechanisms underlying the regulation of p53 stability. In this study, we show that p53-inducible gene 3 (PIG3), which is a transcriptional target of p53, regulates p53 stability. Overexpression of PIG3 stabilized both endogenous and transfected wild-type p53, whereas a knockdown of PIG3 lead to a reduction in both endogenous and UV-induced p53 levels in p53-proficient human cancer cells. Using both in vivo and in vitro ubiquitination assays, we found that PIG3 suppressed both ubiquitination- and MDM2-dependent proteasomal degradation of p53. Notably, we demonstrate that PIG3 interacts directly with MDM2 and promoted MDM2 ubiquitination. Moreover, elimination of endogenous PIG3 in p53-proficient HCT116 cells decreased p53 phosphorylation in response to UV irradiation. These results suggest an important role for PIG3 in regulating intracellular p53 levels through the inhibition of p53 ubiquitination.